810 related articles for article (PubMed ID: 15184499)
21. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
22. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L
Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
[TBL] [Abstract][Full Text] [Related]
23. Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo.
Tonkin DR; He J; Barbour G; Haskins K
J Immunol; 2008 Oct; 181(7):4516-22. PubMed ID: 18802054
[TBL] [Abstract][Full Text] [Related]
24. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation.
Siemasko KF; Gao J; Calder VL; Hanna R; Calonge M; Pflugfelder SC; Niederkorn JY; Stern ME
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5434-40. PubMed ID: 18658093
[TBL] [Abstract][Full Text] [Related]
25. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
[TBL] [Abstract][Full Text] [Related]
26. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
27. Role of regulatory T cells for the treatment of type 1 diabetes mellitus.
Jaeckel E; Mpofu N; Saal N; Manns MP
Horm Metab Res; 2008 Feb; 40(2):126-36. PubMed ID: 18283631
[TBL] [Abstract][Full Text] [Related]
28. Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy.
Gliwiński M; Iwaszkiewicz-Grześ D; Wołoszyn-Durkiewicz A; Tarnowska M; Żalińska M; Hennig M; Zielińska H; Dukat-Mazurek A; Zielkowska-Dębska J; Zieliński M; Jaźwińska-Curyłło A; Owczuk R; Jarosz-Chobot P; Bossowski A; Szadkowska A; Młynarski W; Marek-Trzonkowska N; Moszkowska G; Siebert J; Myśliwiec M; Trzonkowski P
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32098895
[TBL] [Abstract][Full Text] [Related]
29. Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand.
Glinka Y; Chang Y; Prud'homme GJ
Mol Ther; 2006 Oct; 14(4):578-87. PubMed ID: 16790365
[TBL] [Abstract][Full Text] [Related]
30. CD4+CD25+ T cells as immunoregulatory T cells in vitro.
Chai JG; Tsang JY; Lechler R; Simpson E; Dyson J; Scott D
Eur J Immunol; 2002 Aug; 32(8):2365-75. PubMed ID: 12209650
[TBL] [Abstract][Full Text] [Related]
31. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.
Grinberg-Bleyer Y; Saadoun D; Baeyens A; Billiard F; Goldstein JD; Grégoire S; Martin GH; Elhage R; Derian N; Carpentier W; Marodon G; Klatzmann D; Piaggio E; Salomon BL
J Clin Invest; 2010 Dec; 120(12):4558-68. PubMed ID: 21099113
[TBL] [Abstract][Full Text] [Related]
32. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
33. A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity.
Qin HY; Mukherjee R; Lee-Chan E; Ewen C; Bleackley RC; Singh B
Int Immunol; 2006 Jul; 18(7):1001-15. PubMed ID: 16675487
[TBL] [Abstract][Full Text] [Related]
34. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
Xia G; He J; Zhang Z; Leventhal JR
Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
[TBL] [Abstract][Full Text] [Related]
35. Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice.
Yeh LT; Miaw SC; Lin MH; Chou FC; Shieh SJ; Chuang YP; Lin SH; Chang DM; Sytwu HK
J Immunol; 2013 Jul; 191(2):594-607. PubMed ID: 23752610
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes.
Kawamoto K; Pahuja A; Nettles A; Honkanen-Scott M; Bansal-Pakala P
Autoimmunity; 2012 Jun; 45(4):310-9. PubMed ID: 22390157
[TBL] [Abstract][Full Text] [Related]
37. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist.
Lin CH; Hünig T
Eur J Immunol; 2003 Mar; 33(3):626-38. PubMed ID: 12616483
[TBL] [Abstract][Full Text] [Related]
38. Low CD25 on autoreactive Tregs impairs tolerance via low dose IL-2 and antigen delivery.
Hotta-Iwamura C; Benck C; Coley WD; Liu Y; Zhao Y; Quiel JA; Tarbell KV
J Autoimmun; 2018 Jun; 90():39-48. PubMed ID: 29439835
[TBL] [Abstract][Full Text] [Related]
39. In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.
Guo X; Jie Y; Ren D; Zeng H; Zhang Y; He Y; Pan Z
Hum Immunol; 2012 Nov; 73(11):1061-7. PubMed ID: 22939904
[TBL] [Abstract][Full Text] [Related]
40. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
